SCHEMBL6538

SCHEMBL6538

[CH]=CC[CH]F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131237 0.71
SCHEMBL8769427 0.64
SCHEMBL3026290 0.60
SCHEMBL3026292 0.60
SCHEMBL477843 0.59
SCHEMBL9051949 0.58
SCHEMBL11820206 0.58
SCHEMBL5517923 0.58
SCHEMBL1409300 0.58
SCHEMBL2647936 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230299300-A1 POSITIVE ELECTRODE SLURRY AND SECONDARY BATTERY PREPARED THEREFROM CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2023-09-21 US disclosed
EP-4216316-A1 POSITIVE ELECTRODE SLURRY, AND SECONDARY BATTERY PREPARED THEREFROM Contemporary Amperex Technology Co., Limited (CN) 2023-07-26 EP disclosed
WO-2023097432-A1 POSITIVE ELECTRODE SLURRY, AND SECONDARY BATTERY PREPARED THEREFROM 宁德时代新能源科技股份有限公司 2023-06-08 WO disclosed
US-9624182-B2 Compounds as lysophosphatidic acid receptor antagonists AMIRA PHARMACEUTICALS, INC. (US) 2017-04-18 US disclosed
US-20150329502-A1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2015-11-19 US disclosed
US-9090573-B2 Compounds as lysophosphatidic acid receptor antagonists AMIRA PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-20120289522-A1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC. 2012-11-15 US disclosed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed